Prophylactic Activation of Neuroprotective Stress Response Pathways by Dietary and Behavioral Manipulations

被引:88
作者
Mattson M.P. [1 ]
Duan W. [1 ]
Wan R. [1 ]
Guo Z. [1 ]
机构
[1] Laboratory of Neurosciences, National Institute on Aging Gerontology Research Center, Baltimore
来源
NeuroRX | 2004年 / 1卷 / 1期
关键词
Alzheimer's disease; BDNF; heat shock; neurogenesis; neurotrophic factors; oxidative stress; Parkinson's disease; serotonin; stroke;
D O I
10.1602/neurorx.1.1.111
中图分类号
学科分类号
摘要
It is well established that when most types of cells, including neurons, are exposed to a mild stress they increase their ability to resist more severe stress. This "preconditioning" phenomenon involves up-regulation of genes that encode cytoprotective proteins such as heat-shock proteins and growth factors. We found that a similar beneficial cellular stress response can be induced in neurons throughout the brain by a "meal-skipping" dietary restriction (DR) regimen in rats and mice. DR is effective in protecting neurons and improving functional outcome in models of stroke, Alzheimer's, Parkinson's and Huntington's diseases. DR induces an increase in the levels of brain-derived neurotrophic factor (BDNF) and heat-shock proteins in neurons. DR also stimulates neurogenesis in the hippocampus, and BDNF plays a role in this effect of DR. Physical exercise and environmental enrichment are two other manipulations that have been shown to induce BDNF expression in the brain, presumably because it is a mild cellular stress. When taken together with epidemiological and clinical studies in humans, the data from animal studies suggest that it may be possible to reduce the risk for age-related neurodegenerative disorders through dietary and behavioral modifications that act by promoting neuronal plasticity and survival. © 2004 The American Society for Experimental NeuroTherapeutics, Inc.
引用
收藏
页码:111 / 116
页数:5
相关论文
共 68 条
  • [1] Mattson M., Culmsee C., Yu Z., Apoptotic and antiapoptotic mechanisms in stroke, Cell Tissue Res, 301, pp. 173-187, (2000)
  • [2] Mattson M., Apoptosis in neurodegenerative disorders, Nat Rev Mol Cell Biol, 1, pp. 120-129, (2000)
  • [3] Cooper J., Schapira A., Mitochondrial dysfunction in neurodegeneration, J Bioenerg Biomembr, 29, pp. 175-183, (1997)
  • [4] Alexi T., Borlongan C., Faull R., Williams C., Clark R., Gluckman P., Hughes P., Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases, Prog Neurobiol, 60, pp. 409-470, (2000)
  • [5] Back T., Pathophysiology of the ischemic penumbra-revision of a concept, Cell Mol Neurobiol, 18, pp. 621-638, (1998)
  • [6] Mattson M., Neuroprotective signal transduction: relevance to stroke, Neurosci Biobehav Rev, 21, pp. 193-206, (1997)
  • [7] Mattson M., Pedersen W., Duan W., Culmsee C., Camandola S., Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases, Ann NY Acad Sci, 893, pp. 154-175, (1999)
  • [8] Beal M., Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis, Ann Neurol, 44, (1998)
  • [9] Mattson M., Accomplices to neuronal death, Nature, 415, pp. 377-379, (2002)
  • [10] Mattson M., Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders, Neuromolecular Med, 3, pp. 65-94, (2003)